Almirall Completes Decentralized Regulatory Approval Procedure for Efinaconazole in Europe
Almirall, S.A. has completed the decentralized regulatory procedure in Europe for efinaconazole (Jublia), a triazole antifungal compound indicated for onychomycosis . The successful completion of this procedure is the final step before national marketing authorizations can be granted by European countries. Work with the national regulatory authorities is now underway, and marketing authorizations are expected […]